Article Contents ::
- 1 Details About Generic Salt :: Buspiron
- 2 Main Medicine Class:: Antianxiety
- 3 (byoo-SPY-rone HIGH-droe-KLOR-ide) BuSpar, Apo-Buspirone, Bustab, Gen-Buspirone, Linbuspirone, Novo-Buspirone, Nu-Buspirone, PMS-Buspirone Class: Antianxiety
- 4 Drugs Class ::
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
Details About Generic Salt :: Buspiron
Main Medicine Class:: Antianxiety
(byoo-SPY-rone HIGH-droe-KLOR-ide)
BuSpar, Apo-Buspirone, Bustab, Gen-Buspirone, Linbuspirone, Novo-Buspirone, Nu-Buspirone, PMS-Buspirone
Class: Antianxiety
Drugs Class ::
Action Mechanism unknown; does not exert anticonvulsant or muscle relaxant effects.
Indications for Drugs ::
Indications Treatment of anxiety disorders; short-term relief of anxiety symptoms. Unlabeled use(s): Reduction of symptoms of PMS.
Drug Dose ::
Route/Dosage
ADULTS: INITIAL DOSE: PO 5 mg tid; may increase by 5 mg/day q 2 to 3 days prn (maximum 60 mg/day in divided doses).
Contraindication ::
Contraindications Severe liver and kidney impairment.
Drug Precautions ::
Precautions
Pregnancy: Category B. Lactation: Undetermined. Nursing should be avoided. Children < 18 yr: Safety and efficacy not established.
PATIENT CARE CONSIDERATIONS |
|
Drug Side Effects ::
Adverse Reactions
CV: Chest pain; cerebrovascular accident; CHF; MI. CNS: Dizziness; headache; nervousness; lightheadedness; insomnia; excitement; dream disturbances. GI: Nausea. HEMA: Eosinophilia; leukopenia; thrombocytopenia.
Drug Mode of Action ::
Action Mechanism unknown; does not exert anticonvulsant or muscle relaxant effects.
Drug Interactions ::
Interactions
Haloperidol: May elevate haloperidol serum levels. MAO inhibitors: May elevate BP. Trazodone: May elevate serum concentrations of ALT.
Drug Assesment ::
Assessment/Interventions
- Obtain patient history, including drug history and any known allergies. Assess for drug abuse potential and suicidal tendencies.
- If patient is currently taking benzodiazepines or other sedative-hypnotic drugs, gradually taper dosages of these drugs until discontinued because buspirone HCl will not block withdrawal symptoms.
- If patient is currently taking digoxin, assess for cardiac arrhythmias or signs of escalating symptoms of CHF.
- If patient has history of drug misuse or abuse, monitor for behaviors such as drug tolerance or drug seeking.
- If patient displays suicidal tendencies, institute suicide precautions immediately and inform physician.
|
Drug Storage/Management ::
Administration/Storage
- Administer with food, which may decrease rate of absorption and increase bioavailability of drug.
- Store in a dry place at room temperature.
Drug Notes ::
Patient/Family Education
- Advise patient that optimal therapeutic results usually do not occur until after 3 to 4 wk of treatment. However, some improvement may be noted within 7 to 10 days.
- Caution patient to avoid intake of alcoholic beverages and other CNS depressants.
- Instruct patient to report any of the following symptoms to physician: Dizziness, drowsiness, insomnia, nervousness, headache, nausea, fatigue or abnormal movements.
- Advise patient that drug may cause drowsiness and dizziness, and to use caution while driving or performing other tasks requiring mental alertness.
- Instruct patient not to take otc medications without consulting physician.